FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998927617> ?p ?o ?g. }

• W2998927617 endingPage "1919" @default.
• W2998927617 startingPage "1912" @default.
• W2998927617 abstract "Abstract Background Gonorrhea incidence is increasing rapidly in many countries, while antibiotic resistance is making treatment more difficult. Combined with evidence that two meningococcal vaccines are likely partially protective against gonorrhea, this has renewed interest in a gonococcal vaccine, and several candidates are in development. Key questions are how protective and long-lasting a vaccine needs to be, and how to target it. We assessed vaccination’s potential impact and the feasibility of achieving the World Health Organization’s (WHO) target of reducing gonorrhea incidence by 90% during 2018–2030, by comparing realistic vaccination strategies under a range of scenarios of vaccine efficacy and duration of protection, and emergence of extensively-resistant gonorrhea. Methods We developed a stochastic transmission-dynamic model, incorporating asymptomatic and symptomatic infection and heterogeneous sexual behavior in men who have sex with men (MSM). We used data from England, which has a comprehensive, consistent nationwide surveillance system. Using particle Markov chain Monte Carlo methods, we fitted to gonorrhea incidence in 2008–2017, then used Bayesian forecasting to examine an extensive range of scenarios. Results Even in the worst-case scenario of untreatable infection emerging, the WHO target is achievable if all MSM attending sexual health clinics receive a vaccine offering ≥ 52% protection for ≥ 6 years. A vaccine conferring 31% protection (as estimated for MeNZB) for 2–4 years could reduce incidence in 2030 by 45% in the worst-case scenario, and by 75% if &gt; 70% of resistant gonorrhea remains treatable. Conclusions Even a partially-protective vaccine, delivered through a realistic targeting strategy, could substantially reduce gonorrhea incidence, despite antibiotic resistance." @default.
• W2998927617 created "2020-01-23" @default.
• W2998927617 creator A5002017011 @default.
• W2998927617 creator A5042745262 @default.
• W2998927617 creator A5058915559 @default.
• W2998927617 date "2020-01-06" @default.
• W2998927617 modified "2023-10-12" @default.
• W2998927617 title "Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics" @default.
• W2998927617 cites W1501586228 @default.
• W2998927617 cites W1981223938 @default.
• W2998927617 cites W1983960504 @default.
• W2998927617 cites W2030590285 @default.
• W2998927617 cites W2031866988 @default.
• W2998927617 cites W2064805848 @default.
• W2998927617 cites W2103447638 @default.
• W2998927617 cites W2147357149 @default.
• W2998927617 cites W2160619907 @default.
• W2998927617 cites W2273624252 @default.
• W2998927617 cites W2304991599 @default.
• W2998927617 cites W2328223148 @default.
• W2998927617 cites W2469559253 @default.
• W2998927617 cites W2604730145 @default.
• W2998927617 cites W2725319213 @default.
• W2998927617 cites W2732332911 @default.
• W2998927617 cites W2735393008 @default.
• W2998927617 cites W2765565742 @default.
• W2998927617 cites W2765649019 @default.
• W2998927617 cites W2771011086 @default.
• W2998927617 cites W2779019546 @default.
• W2998927617 cites W2791989381 @default.
• W2998927617 cites W2795207334 @default.
• W2998927617 cites W2811398709 @default.
• W2998927617 cites W2837231096 @default.
• W2998927617 cites W2904963332 @default.
• W2998927617 cites W2915717865 @default.
• W2998927617 cites W2935914238 @default.
• W2998927617 cites W2951370905 @default.
• W2998927617 cites W2951744341 @default.
• W2998927617 cites W887825220 @default.
• W2998927617 doi "https://doi.org/10.1093/cid/ciz1241" @default.
• W2998927617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7643747" @default.
• W2998927617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31905399" @default.
• W2998927617 hasPublicationYear "2020" @default.
• W2998927617 type Work @default.
• W2998927617 sameAs 2998927617 @default.
• W2998927617 citedByCount "17" @default.
• W2998927617 countsByYear W29989276172020 @default.
• W2998927617 countsByYear W29989276172021 @default.
• W2998927617 countsByYear W29989276172022 @default.
• W2998927617 countsByYear W29989276172023 @default.
• W2998927617 crossrefType "journal-article" @default.
• W2998927617 hasAuthorship W2998927617A5002017011 @default.
• W2998927617 hasAuthorship W2998927617A5042745262 @default.
• W2998927617 hasAuthorship W2998927617A5058915559 @default.
• W2998927617 hasBestOaLocation W29989276171 @default.
• W2998927617 hasConcept C120665830 @default.
• W2998927617 hasConcept C121332964 @default.
• W2998927617 hasConcept C144024400 @default.
• W2998927617 hasConcept C149923435 @default.
• W2998927617 hasConcept C203014093 @default.
• W2998927617 hasConcept C22070199 @default.
• W2998927617 hasConcept C2776939746 @default.
• W2998927617 hasConcept C2776983459 @default.
• W2998927617 hasConcept C2778082588 @default.
• W2998927617 hasConcept C2779166590 @default.
• W2998927617 hasConcept C3013748606 @default.
• W2998927617 hasConcept C41008148 @default.
• W2998927617 hasConcept C501593827 @default.
• W2998927617 hasConcept C61511704 @default.
• W2998927617 hasConcept C71924100 @default.
• W2998927617 hasConcept C761482 @default.
• W2998927617 hasConcept C76155785 @default.
• W2998927617 hasConcept C86803240 @default.
• W2998927617 hasConcept C89423630 @default.
• W2998927617 hasConcept C94665300 @default.
• W2998927617 hasConcept C99454951 @default.
• W2998927617 hasConceptScore W2998927617C120665830 @default.
• W2998927617 hasConceptScore W2998927617C121332964 @default.
• W2998927617 hasConceptScore W2998927617C144024400 @default.
• W2998927617 hasConceptScore W2998927617C149923435 @default.
• W2998927617 hasConceptScore W2998927617C203014093 @default.
• W2998927617 hasConceptScore W2998927617C22070199 @default.
• W2998927617 hasConceptScore W2998927617C2776939746 @default.
• W2998927617 hasConceptScore W2998927617C2776983459 @default.
• W2998927617 hasConceptScore W2998927617C2778082588 @default.
• W2998927617 hasConceptScore W2998927617C2779166590 @default.
• W2998927617 hasConceptScore W2998927617C3013748606 @default.
• W2998927617 hasConceptScore W2998927617C41008148 @default.
• W2998927617 hasConceptScore W2998927617C501593827 @default.
• W2998927617 hasConceptScore W2998927617C61511704 @default.
• W2998927617 hasConceptScore W2998927617C71924100 @default.
• W2998927617 hasConceptScore W2998927617C761482 @default.
• W2998927617 hasConceptScore W2998927617C76155785 @default.
• W2998927617 hasConceptScore W2998927617C86803240 @default.
• W2998927617 hasConceptScore W2998927617C89423630 @default.
• W2998927617 hasConceptScore W2998927617C94665300 @default.
• W2998927617 hasConceptScore W2998927617C99454951 @default.
• W2998927617 hasFunder F4320332161 @default.

• next